Biotech Stock Comparison - Canada

Compare Canadian biotech stocks. See a comparison of key indicators, including biotechnology stock price targets and Wall Street analyst recommendations.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
TSE:BHCBausch Health Companies
C$35.96
0.01 (0.03%)
C$50.26
(39.78% Upside)
C$12.89B
-10.20
67.98%
3Buy
1Hold
0Sell
Strong Buy
TSE:ASPAcerus Pharmaceuticals
C$0.05
C$69.19M
-1.00
33.33%
TSE:THTheratechnologies
C$4.34
-0.13 (-2.91%)
C$10.05
(131.63% Upside)
C$412.06M
43.20%
2Buy
0Hold
0Sell
Moderate Buy
TSE:AUPAurinia Pharmaceuticals
C$14.29
-0.26 (-1.79%)
C$34.43
(140.94% Upside)
C$1.83B
-28.57%
5Buy
0Hold
0Sell
Strong Buy
TSE:BLUBELLUS Health
C$3.50
-0.01 (-0.28%)
C$12.57
(259.03% Upside)
C$274.18M
8.11%
3Buy
0Hold
0Sell
Strong Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
TSE:THTheratechnologies
premium
premium
Buy
premium
premium
Reiterated
TSE:BHCBausch Health Companies
premium
premium
Buy
premium
premium
Reiterated
TSE:AUPAurinia Pharmaceuticals
premium
premium
Buy
premium
premium
Reiterated
TSE:BLUBellus Health Inc.
premium
premium
Buy
premium
premium
Reiterated
TSE:AUPAurinia Pharmaceuticals
premium
premium
Buy
premium
premium
Reiterated
TSE:BHCBausch Health Companies
premium
premium
Buy
premium
premium
Reiterated
TSE:AUPAurinia Pharmaceuticals
premium
premium
Buy
premium
premium
Assigned
TSE:THTheratechnologies
premium
premium
Buy
premium
premium
Reiterated
TSE:AUPAurinia Pharmaceuticals
premium
premium
Buy
premium
premium
Assigned
TSE:BLUBellus Health Inc.
premium
premium
Buy
premium
premium
Reiterated

Most Recent Earnings of Biotech Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
TSE:BHCBausch Health Companies
May 04, 2021
2021 (Q1)
1.20 / -2.15
-0.54
-297.67% (-1.61)
TSE:ASPAcerus Pharmaceuticals
May 12, 2021
2021 (Q1)
- / -0.01
-0.008
-37.50% (>-0.01)
TSE:THTheratechnologies
Jul 15, 2021
2021 (Q2)
-0.09 / -0.08
-0.106
20.75% (+0.02)
TSE:AUPAurinia Pharmaceuticals
May 06, 2021
2021 (Q1)
-0.47 / -0.50
-0.198
-153.03% (-0.30)
TSE:BLUBELLUS Health
May 10, 2021
2021 (Q1)
-0.18 / -0.26
-0.245
-4.08% (-0.01)

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
Bausch Health Companies - Strong Buy, based on 4 analyst ratings, 3 Buy, 1 Hold, and 0 Sell.
    Aurinia Pharmaceuticals - Strong Buy, based on 5 analyst ratings, 5 Buy, 0 Hold, and 0 Sell.
      BELLUS Health - Strong Buy, based on 3 analyst ratings, 3 Buy, 0 Hold, and 0 Sell.
        Are Biotech stocks overpriced?
        Bausch Health Companies's stock price is currently C$35.96, and its average 12-month price target is C$50.26.
          Acerus Pharmaceuticals's stock price is currently C$0.05, and its average 12-month price target is N/A.
            Theratechnologies's stock price is currently C$4.34, and its average 12-month price target is C$10.05.
              Aurinia Pharmaceuticals's stock price is currently C$14.29, and its average 12-month price target is C$34.43.
                BELLUS Health's stock price is currently C$3.50, and its average 12-month price target is C$12.57.
                  Which Biotech stocks pay dividends?
                  Bausch Health Companies does not currently pay dividends.
                    Acerus Pharmaceuticals does not currently pay dividends.
                      Theratechnologies does not currently pay dividends.
                        Aurinia Pharmaceuticals does not currently pay dividends.
                          BELLUS Health does not currently pay dividends.